Comparison of clinical efficacy and safety between denosumab and alendronate in postmenopausal women with osteoporosis: a meta-analysis. [electronic resource]
Producer: 20120523Description: 399-408 p. digitalISSN:- 1742-1241
- Aged
- Aged, 80 and over
- Alendronate -- therapeutic use
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized
- Bone Density -- drug effects
- Bone Density Conservation Agents -- therapeutic use
- Denosumab
- Drug-Related Side Effects and Adverse Reactions
- Female
- Humans
- Multicenter Studies as Topic
- Osteoporosis, Postmenopausal -- drug therapy
- Randomized Controlled Trials as Topic
- Risk Factors
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.